Research and Markets (http://www.researchandmarkets.com/research/vjdnq9/global) has announced the addition of the "Global Non-Hodgkin's Lymphoma Epidemiology and Patient Flow Analysis - 2015" report to their offering. The report provides insights ... Individual.com, 4 days ago
Research and Markets: Global Non-Hodgkin's Lymphoma Epidemiology and Patient Flow Analysis 2015-2020 - TMC Net, 4 days ago
RESEARCH AND MARKETS : Global Non-Hodgkin's Lymphoma Epidemiology and Patient Flow Analysis 2015-2020 - 4 Traders, 4 days ago
More from: CNBC, Vision Monday...and 29 other sources
Socioeconomic factors often influenced the decision to eliminate radiation therapy from the treatment of classic non-Hodgkin's lymphoma, according to study results. The trend away from combined-modality therapy — or chemotherapy and radiation ...Orthopedics Today, 3 days ago Early-Stage HL Patients Receiving Suboptimal Therapy General Medicine eJournal, 1 week ago
The case of Cassandra C., a 17-year-old in Connecticut who refused to continue receiving chemotherapy to treat her Hodgkin's lymphoma, poses a genuine ethical dilemma. The dilemma stems from a conflict between two leading ethical principles. One ...Huffington Post, 1 week ago Forcing Teen to Have Chemo Not Troubling to Ethicists MedPage Today, 1 week ago Connecticut Supreme Court: Cassandra 'Not Mature' Enough to Deny Chemotherapy Treatment for Hodgkin's Lymphoma Tech Times, 2 weeks ago BREAKING NEWS: Connecticut Supreme Court rejects mature minor doctrine and rules a 17-year-old girl with Hodgkin's lymphona can be forced to undergo chemotherapy FOXNews.com, 2 weeks ago
More from: Care2, Individual.com...and 1 other sources
Cassandra C. has a form of cancer called Hodgkin lymphoma that, left untreated, would most likely kill her. The good news is that with chemotherapy, doctors give her an 85 percent chance of surviving. At least that would normally be good news. But ...Chicago Tribune, 1 week ago
By: ROGER HOKE - News Editor & MARY MACRAE - Asst. News Editor Brandon Ronning, a sophomore at the University of Dayton, will not be returning to UD this semester after being diagnosed with stage four non-Hodgkin's diffused large B-cell lymphoma. ...Individual.com, 1 week ago
When Charles The playwright who is also a radiation oncologist - was overwhelmed. He knew he had a good story, but never imagined that Vera Peters would be such a draw. I was overwhelmed, Dr. Hayter says. It was beyond any expectation, that ...CBC, 2 weeks ago
VIDEO: The state is trying to forcibly treat a Connecticut teen who is refusing treatment for Hodgkin's lymphoma.
VIDEO: The state is trying to forcibly treat a Connecticut teen who is refusing treatment forABC News, 2 weeks ago Teen Explains Why She Doesn't Want Chemotherapy ABC News, 1 week ago
|Vision Monday, 4 days ago|
> Community home > Groups > Cancer types > Lymphoma, Hodgkin's > Lymphoma, Hodgkin's - Discussion Forum > Visit toMacmillan Cancer Support, 4 hours ago Forum Post: RE: Hives? Help :( Macmillan Cancer Support, 1 week ago Forum Post: Hives? Help :( Macmillan Cancer Support, 1 week ago
BioInvent International (OMXS: BINV) and Cancer Research UK, Cancer Research Technology (CRT), the charity's development and commercialisation arm, and Leukaemia & Lymphoma Research (LLR) are taking itsinvestigational drug, BI-1206, into a ...Ecancer Medicalscience, 4 days ago BioInvent to Launch Collaborative Phase for Bi-1206 Antibody Individual.com, 2 days ago BioInvent inks agreement with Cancer Research U.K., CRT and LLR Center Watch, 3 days ago BioInvent: BioInvent's Bi-1206 Antibody to Enter Collaborative Phase L/Ll Trial Funded and Conducted … Yahoo! Finance, 5 days ago
on your WebpageAdd Widget >Get your members hooked!